MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...

MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory filing ...

It was already clear that Max Verstappen was an F1 superstar in the making and after his first World title triumph in 2021, Red Bull made sure to tie their star asset down to a mega six-year contract, ...